back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-11-07 14:07 Tx date 2025-11-06 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-100,500 vol |
180,000 | |
| Filed 2025-11-07 14:05 Tx date 2025-11-06 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$75,375
+100,500 vol $0.75 each |
875,012 | |
| Filed 2025-11-07 14:04 Tx date 2025-11-06 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+100,500 vol |
280,500 | |
| Filed 2025-11-07 14:01 Tx date 2025-11-06 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Warrants Founder Warrants
54 - Exercise of warrants
|
$-50,089.20
-100,500 vol $0.4984 each |
0 | |
| Filed 2025-11-07 13:59 Tx date 2025-11-06 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$50,089
+100,500 vol $0.4984 each |
774,512 | |
| Filed 2025-11-06 13:42 Tx date 2025-11-02 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-150,000
-18,750 vol $8.00 each |
1,275,500 | |
| Filed 2025-08-11 19:26 Tx date 2025-05-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$271,000
+50,000 vol $5.42 each |
1,294,250 | |
| Filed 2025-04-14 13:59 Tx date 2025-03-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-400,000
-50,000 vol $8.00 each |
1,244,250 | |
| Filed 2025-03-27 13:59 Tx date 2025-03-25 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,336,400
+260,000 vol $5.14 each |
1,294,250 | |
| Filed 2024-05-22 23:21 Tx date 2024-05-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,584,000
+400,000 vol $3.96 each |
1,034,250 | |
| Filed 2023-08-20 00:35 Tx date 2023-08-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$100,002
+14,286 vol $7.00 each |
674,012 | |
| Filed 2023-03-29 11:22 Tx date 2023-03-28 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,894
+700 vol $4.14 each |
659,726 | |
| Filed 2023-03-29 11:21 Tx date 2023-03-28 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,463
+600 vol $4.11 each |
659,026 | |
| Filed 2023-03-29 11:19 Tx date 2023-03-28 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,680
+4,800 vol $4.10 each |
658,426 | |
| Filed 2022-12-12 19:55 Tx date 2022-12-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$731,500
+190,000 vol $3.85 each |
634,250 | |
| Filed 2022-08-25 02:39 Tx date 2022-08-22 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,819
+6,800 vol $1.15 each |
653,626 | |
| Filed 2022-08-22 12:47 Tx date 2022-08-19 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$770.00
+700 vol $1.10 each |
646,826 | |
| Filed 2022-08-20 11:20 Tx date 2022-08-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,925
+8,500 vol $1.05 each |
646,126 | |
| Filed 2022-08-17 17:38 Tx date 2022-08-17 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,625
+2,500 vol $1.05 each |
637,626 | |
| Filed 2022-07-02 12:36 Tx date 2022-06-29 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Helliwell, James Allen
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,900
+9,900 vol $1.00 each |
635,126 |